Dendreon

Dendreon company information, Employees & Contact Information

Explore related pages

Related company profiles:

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.

Company Details

Employees
628
Founded
-
Address
1700 Saturn Way, Seal Beach,ca 90740,united States
Phone
(877) 256-4545
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Seal Beach , CA
Looking for a particular Dendreon employee's phone or email?

Dendreon Questions

News

Landmark approval for Dendreon's cancer vaccine - Nature

Landmark approval for Dendreon's cancer vaccine Nature

Georgia helps Dendreon serve patients throughout the Eastern region - Georgia Department of Economic Development

Georgia helps Dendreon serve patients throughout the Eastern region Georgia Department of Economic Development

Dendreon leveraging Provenge network to launch cell therapy CDMO biz - BioProcess International

Dendreon leveraging Provenge network to launch cell therapy CDMO biz BioProcess International

Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site - Fierce Pharma

Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site Fierce Pharma

Sipuleucel-T Shows Potential With New Trial Data, But Questions Regarding Clinical Relevance Remain - Targeted Oncology

Sipuleucel-T Shows Potential With New Trial Data, But Questions Regarding Clinical Relevance Remain Targeted Oncology

AbbVie puts $60M into ex-Dendreon CEO’s company in autoimmune drug pact - BioPharma Dive

AbbVie puts $60M into ex-Dendreon CEO’s company in autoimmune drug pact BioPharma Dive

Dendreon and Shoreline Enter CMC Agreement - Contract Pharma

Dendreon and Shoreline Enter CMC Agreement Contract Pharma

Second Path: Dendreon Seeks Growth beyond Provenge - Genetic Engineering and Biotechnology News

Second Path: Dendreon Seeks Growth beyond Provenge Genetic Engineering and Biotechnology News

Biotech’s pitfalls tripped up Dendreon, led it to bankruptcy - The Seattle Times

Biotech’s pitfalls tripped up Dendreon, led it to bankruptcy The Seattle Times

cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide - Wiley Online Library

cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide Wiley Online Library

In Juno patient deaths, echoes seen of earlier failed company - statnews.com

In Juno patient deaths, echoes seen of earlier failed company statnews.com

Dendreon Biopharmaceutical Manufacturing Plant, Seattle - Pharmaceutical Technology

Dendreon Biopharmaceutical Manufacturing Plant, Seattle Pharmaceutical Technology

Valeant to sell Dendreon unit to China's Sanpower for $820 million - Reuters

Valeant to sell Dendreon unit to China's Sanpower for $820 million Reuters

Valeant buys bankrupt drug maker Dendreon for $495 million - GeekWire

Valeant buys bankrupt drug maker Dendreon for $495 million GeekWire

Long-suffering Dendreon finds new avatar as contract manufacturer for cell therapy partners - Fierce Pharma

Long-suffering Dendreon finds new avatar as contract manufacturer for cell therapy partners Fierce Pharma

Dendreon ups its Provenge marketing game with help from NBA all-star Grant Hill - Fierce Pharma

Dendreon ups its Provenge marketing game with help from NBA all-star Grant Hill Fierce Pharma

Dendreon changes hands—again—in $868M deal that keeps seller Sanpower in the game - Fierce Pharma

Dendreon changes hands—again—in $868M deal that keeps seller Sanpower in the game Fierce Pharma

China's Sanpower takes on expensive Provenge manufacturing with Dendreon deal - Fierce Pharma

China's Sanpower takes on expensive Provenge manufacturing with Dendreon deal Fierce Pharma

Dendreon, done in by expensive, complex manufacturing, files for bankruptcy - Fierce Pharma

Dendreon, done in by expensive, complex manufacturing, files for bankruptcy Fierce Pharma

Dendreon eyes real-world data boost for lagging prostate cancer med Provenge - Fierce Pharma

Dendreon eyes real-world data boost for lagging prostate cancer med Provenge Fierce Pharma

Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group - PR Newswire

Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group PR Newswire

Dendreon chairwoman figures Provenge growth, infrastructure can pave its way into CAR-T - Fierce Pharma

Dendreon chairwoman figures Provenge growth, infrastructure can pave its way into CAR-T Fierce Pharma

Sanpower Group Completes The Acquisition Of Dendreon From Valeant - BioSpace

Sanpower Group Completes The Acquisition Of Dendreon From Valeant BioSpace

Dendreon to Pursue Cancer Drug Operation Sale or Reorganization in Bankruptcy - The Wall Street Journal

Dendreon to Pursue Cancer Drug Operation Sale or Reorganization in Bankruptcy The Wall Street Journal

Dendreon files for Chapter 11 protection - Financier Worldwide

Dendreon files for Chapter 11 protection Financier Worldwide

Seattle biotech Dendreon files for bankruptcy, considers sale - GeekWire

Seattle biotech Dendreon files for bankruptcy, considers sale GeekWire

Dendreon Reveals Survival Data for Provenge in Metastatic Prostate Cancer Study - drugdiscoverytrends.com

Dendreon Reveals Survival Data for Provenge in Metastatic Prostate Cancer Study drugdiscoverytrends.com

Dendreon Appoints New CEO - Orange County Business Journal

Dendreon Appoints New CEO Orange County Business Journal

3 biotech stocks battle the ‘Dendreon Effect’ - MarketWatch

3 biotech stocks battle the ‘Dendreon Effect’ MarketWatch

Troubled Dendreon Sells Off NJ Plant - Genetic Engineering and Biotechnology News

Troubled Dendreon Sells Off NJ Plant Genetic Engineering and Biotechnology News

Dendreon Plots Reinvention as Contract Manufacturer - Orange County Business Journal

Dendreon Plots Reinvention as Contract Manufacturer Orange County Business Journal

Former Dendreon CEO debuts new public company in reverse merger - BioPharma Dive

Former Dendreon CEO debuts new public company in reverse merger BioPharma Dive

Dendreon files for bankruptcy - Pharmafile

Dendreon files for bankruptcy Pharmafile

Why ex-Dendreon CEO's new biotech startup could succeed where Dendreon failed - The Business Journals

Why ex-Dendreon CEO's new biotech startup could succeed where Dendreon failed The Business Journals

Dendreon wins IQWiG U-turn for its immunotherapy Provenge - PMLiVE

Dendreon wins IQWiG U-turn for its immunotherapy Provenge PMLiVE

Former Dendreon CEO Secures $48M For Cancer Immunotherapy Startup - Forbes

Former Dendreon CEO Secures $48M For Cancer Immunotherapy Startup Forbes

In a Television Carnival, Buy, Sell or Cringe (Published 2007) - The New York Times

In a Television Carnival, Buy, Sell or Cringe (Published 2007) The New York Times

Dendreon's $93,000 prostate cancer drug: Is Provenge worth it? - CBS News

Dendreon's $93,000 prostate cancer drug: Is Provenge worth it? CBS News

Dendreon lays off 77 including CEO W. Thomas Amick - The Business Journals

Dendreon lays off 77 including CEO W. Thomas Amick The Business Journals

Valeant lead bidder for troubled Dendreon - PMLiVE

Valeant lead bidder for troubled Dendreon PMLiVE

Dendreon Bags FDA Approval for Prostate Cancer Vaccine Provenge - Genetic Engineering and Biotechnology News

Dendreon Bags FDA Approval for Prostate Cancer Vaccine Provenge Genetic Engineering and Biotechnology News

Valeant uncouples Dendreon and skincare brands to cut debt - PMLiVE

Valeant uncouples Dendreon and skincare brands to cut debt PMLiVE

Lindsay Rocco to lead corporate communications at Dendreon - PMLiVE

Lindsay Rocco to lead corporate communications at Dendreon PMLiVE

Dendreon’s cancer vaccine wins EU approval - PMLiVE

Dendreon’s cancer vaccine wins EU approval PMLiVE

Company Uses Nanobots To Fight Cancer…But Its Not At All What You Thought It Would Be - SingularityHub

Company Uses Nanobots To Fight Cancer…But Its Not At All What You Thought It Would Be SingularityHub

Top Dendreon Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant